On June 29, 2016, Qualitest received the prestigious Frost & Sullivan 2016 Global Software Testing Services Customer Value Leadership Award in a ceremony at the Jumeirah Carlton Tower Hotel in London.  Qualitest VP’s Aviram Shotten and Jim Brooks attended the banquet to collect the award as seen in the photo.  The banquet brought together top executives to celebrate their achievements.  We won this award with an average rating of 9.3 on F&S’s 1.0-to-10.0 scale; halfway up from the 8.6 average by the next 2 closest anonymous competitors.

Frost & Sullivan’s Best Practices Awards recognize companies throughout a range of regional and global markets for superior leadership, technological innovation, customer service, and strategic product development.

These companies are predicted to encourage significant growth in their industries, have identified emerging trends before they became the standard in the marketplace, and have created advanced technologies that will catalyze and transform industries in the near future.  Frost & Sullivan’s industry analyst team benchmarks market participants and measures their performance through independent, primary interviews, and secondary industry research in order to evaluate and identify best practices.  F&S’s intent is to help drive innovation, excellence and a positive change in the global economy by recognizing best-in-class products, companies and individuals, providing awards to companies inspired by visionary growth, innovation, and leadership.

The write-up of our award concludes by stating: “In the growing software testing services market, Qualitest stands out with its strong thought leadership, innovation, and flexibility.  Purely focused on testing, the company differentiates itself in the market by providing superior customer service experience enabled by its deep expertise in testing and industry knowledge and a stronger emphasis on their clients’ business context.”

According to Frost & Sullivan Industry Director Jessy Cavazos “Qualitest’s global presence in the United States, Europe, the Middle East, and India enables it to leverage a mix of off-shore, on-site, and on-shore options to provide right-shore testing. Its solutions are tailored to end-user needs, whether those solutions are delivered by a single testing team working in just one location, or through the combined efforts of its testing experts worldwide”.  “Qualitest makes testers available anywhere in the world, even in highly specific regions due to distinctive network conditions, language, localization, or time-to-market requirements.”

“Qualitest has demonstrated consistently high growth rates, underlining its ability to retain customers while adding new ones,” noted Cavazos.  “The company has also been able to grow with current accounts, migrating from disparate, regional customers to global ones.” This year’s ceremony included a networking reception followed by a formal black-tie dinner and celebration reception.  Additionally, attendees were invited to join a one-hour workshop titled Understanding the Eco-system of Smart Cities and Implications for Your Company.   Archana Amarnath, the global director of Frost & Sullivan’s Visionary Innovation Group, has completed extensive analysis on the Global Smart City market and facilitated a discussion covering new findings that drive the market globally, specifically:

  • Parameters of a smart city model
  • Top 26 smart cities in the next decade
  • New business models
  • Top Funding models in the Smart City Ecosystem

Other Frost & Sullivan award recipients included Plantronics, RSA, and two divisions of Siemens.  Other award titles included Global Solar Power New Product Innovation Award, Global Smart Card Company of the Year Award and Global Unified Communications Price/Performance Value Leadership Award.  VECT-HORUS received a Frost & Sullivan’s 2016 Technology Innovation Leadership Award at the ceremony for their work on delivering pharmaceutics and medical imagery, which includes a method of bypassing the blood-brain barrier which blocks nearly 100% of large molecules (peptides, antibodies, proteins, e.g.) and more than 98% of all small molecule drugs, and building a pipeline for treatments delivered through this method.

For the official write-up for our winning the award, with all of the rationale that went into the decision, click here.